Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with KLRS: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
KLRS
Kalaris Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
KLRS
Kalaris Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
KLRS: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No disclosed counterparties: KLRS.
Only KLRS
0
None
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
KLRS, dashed
AMGN
Amgen Inc
Change
477.74
▲
+3.57%
Mkt cap
$249.4B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
KLRS
Kalaris Therapeutics, Inc.
Change
2.10
▲
+5.15%
Regular session
Nov 4 '26
Mkt cap
$48.8M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 4 '26
AMGN
Amgen Inc
vs
KLRS
Kalaris Therapeutics, Inc.
477.74
▲
+3.57%
Price
2.10
▲
+5.15%
$249.4B
Mkt cap
$48.8M
Q3 FY26
$10.4B
Revenue
—
FY25
$36.8B
Revenue
—
Change
Change
AMGN
477.74
▲
+3.57%
vs
KLRS
2.10
▲
+5.15%
Regular session
Nov 4 '26